Clinical Significance of Thyrotrophin Binding Inhibitor Immunoglobulins in Patients with Graves' Disease and Various Types of Thyroiditis
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Parker R, BEIERWALTES W
. Thyroid antibodies during pregnancy and in the newborn. J Clin Endocrinol Metab. 1961; 21:792-8.
DOI: 10.1210/jcem-21-7-792.
View
2.
Inada M, Nishikawa M, Oishi M, Kurata S, Imura H
. Transient thyrotoxicosis associated with painless thyroiditis and low radioactive iodine uptake. Arch Intern Med. 1979; 139(5):597-9.
View
3.
Sugenoya A, Kidd A, Row V, Volpe R
. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab. 1979; 48(3):398-402.
DOI: 10.1210/jcem-48-3-398.
View
4.
Endo K, Kasagi K, Konishi J, Ikekubo K, Okuno T, Takeda Y
. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1978; 46(5):734-9.
DOI: 10.1210/jcem-46-5-734.
View
5.
Smith B, Hall R
. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974; 2(7878):427-31.
DOI: 10.1016/s0140-6736(74)91815-7.
View